Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
about
Biologic agents in juvenile spondyloarthropathiesGolimumab for the treatment of ulcerative colitisA bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settingsDR*W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. tuberculosis infection and its resting memory pool after BCG vaccination.Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review.Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infectionsChoice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.Classic and new diagnostic approaches to childhood tuberculosisPsoriatic disease and tuberculosis nowadays.Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonistsDynamic QuantiFERON Response in Psoriasis Patients Taking Long-Term Biologic Therapy.Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patientsSafety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease.Infliximab in the treatment of rheumatoid arthritisCost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease.Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy.Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Golimumab for moderately to severely active ulcerative colitis.Performance of QuantiFERON(®)-TB Gold In-Tube assay in children receiving disease modifying anti-rheumatic drugs.Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents.Screening for latent tuberculosis infection in psoriasis and psoriatic arthritis patients in a tuberculosis-endemic country: a comparison of the QuantiFERON®-TB Gold In-Tube test and tuberculin skin test.Appropriate screening for leishmaniasis before immunosuppressive treatments.QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States.Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy.Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy.Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening.The value of an immune response to Mycobacterium tuberculosis in patients with chronic posterior uveitis revisited: utility of the new IGRAs.Challenges in screening for latent tuberculosis in inflammatory bowel disease prior to biologic treatment: a UK cohort studyInterferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatmentIFN-γ-release assays to diagnose TB infection in the immunocompromised individual
P2860
Q26766263-2F754304-A02B-46C4-9A8C-43420DBD16D4Q28236322-16413260-98C7-4F8A-872D-34D1A21EB4E6Q28481078-92718E37-8002-406B-8B2B-EF69E1B71253Q33500154-F4F5A2A9-32DE-4800-B83F-DF256BB24FD2Q33939033-CFBACCE6-B1DB-485D-A621-602FE9CD2BD5Q35205539-5686389E-2514-464C-B074-2008ECD66141Q35237588-8342AD25-03B4-4764-9438-043C082C2081Q35864845-A59024E0-C581-4C27-930E-C838498C3E5AQ35974892-CC790C77-28A3-4BE5-87FE-298D1724C274Q36246140-F23DAE96-8DA5-4DDA-8A02-F11F248286CCQ36923535-FACBEEC3-83F9-4291-8077-866334C354AEQ37166873-68427729-C597-47EF-925A-1359BAF67F65Q37223472-421803D6-31E6-41C0-90C7-0C54D028F247Q37303230-FF18ECF8-8B3F-4E59-9673-4205878B7345Q37467519-CBCC3A88-E493-4960-BBA6-22457D8F01A4Q38116751-FBD45281-5364-4552-A3D4-1DDF8F6DBC47Q38255412-27767640-050D-48DA-851B-4777AD2346C6Q38265740-1EB5BE33-480E-4601-9161-4BD2E3D43C82Q38394726-B215C8BF-734C-45D6-8E1E-EF5A9A28AEF9Q38921072-9687D40E-5544-4BED-8EB6-511B6976B27CQ40159900-C486B65B-2A33-48E6-AD70-F7E9A9D273B4Q40752218-F9B2B92A-7288-406B-8548-121314039DA5Q41261895-A652338D-F233-4E31-97C9-F71F9A932B91Q42205252-1D1A8AC2-62C6-4E0A-BFE0-189DDF658365Q42905992-D0E56C50-0B1A-44F7-A0F7-56A0006752BEQ43663890-41E0F7AE-A797-476C-AF24-CC91A8E6C6A0Q44051009-0C09C59F-950F-4E37-8743-47DC84697BEAQ47119702-4812331A-698E-4872-8FD3-6EDE441AAD96Q47546977-10F75C2C-2C89-41EA-BE4E-AA84240B88D8Q47652162-AEE82CFD-D031-40C9-817E-D881E3B77E2EQ51758287-C20131D6-78AD-4E57-9237-3EB97AF2135BQ58856028-F30A8F6A-3217-40B3-8603-07EAFAB53D34Q58924832-A79A56BE-DC35-4B68-B82D-7DFC74B34544Q58924849-ECCB2E8D-507C-4F44-8B24-8B9AAABBBB6A
P2860
Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
@en
type
label
Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
@en
prefLabel
Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
@en
P2860
P921
P1433
P1476
Screening for tuberculosis infection prior to initiation of anti-TNF therapy.
@en
P2093
Kerry A Millington
P2860
P304
P356
10.1016/J.AUTREV.2008.07.011
P50
P5008
P577
2008-08-13T00:00:00Z
2008-12-01T00:00:00Z